Luminate GTM brain

Luminate partners with oncology providers and health plans to deliver nurse-led cancer infusions at home and is developing devices for treatment side effects.

category

Oncology care at home

market profile

  • text: Home infusion shifts eligible oncology treatment out of crowded clinics while requiring coordination with providers and payers.
  • text: Hair loss prevention is a separate investigational device opportunity with established scalp cooling alternatives.

personas

  • title: Oncology practice administrator
    pains:
    • Infusion chairs and staff are under pressure as patient demand grows
    • Maintaining pharmacy control and continuity when care moves home
  • title: Health plan oncology or care management leader
    pains:
    • High treatment costs and member travel burden
    • Need to coordinate coverage and provider participation for home care
  • title: Oncologist
    pains:
    • Protecting clinical oversight when treatment leaves the clinic
    • Managing distressing chemotherapy side effects

icp

  • text: Oncology practices and health systems with infusion clinics and capacity constraints, particularly in the United States.
  • text: Health plans seeking lower-cost oncology care settings and existing provider network continuity.

message pillars

  • text: Bring treatment home under experienced nursing care.
  • text: Keep the existing provider involved and protect oversight.
  • text: Free scarce infusion capacity.

objections

  • objection: Can care be delivered safely outside the clinic?
    response: Review eligibility, clinical protocols, nursing qualifications and escalation pathways with the oncology team before adoption.
  • objection: Will moving infusions disrupt our pharmacy economics and oversight?
    response: Luminate says drug dispensing remains with the originating provider; validate the operating and reimbursement terms in a pilot.
  • objection: Are the side-effect devices approved?
    response: The site describes its devices as preclinical or clinical stage and not FDA approved; distinguish these from the home infusion service.

competitors

  • name: Reimagine Care
    website: https://reimaginecare.com/
    why: Partners with oncology teams on home treatment and virtual cancer care.
  • name: CareCentrix
    website: https://www.carecentrix.com/solutions/oncology-at-home/
    why: Offers oncology at home including immunotherapy infusion coordination.
  • name: Paxman
    why: Scalp cooling alternative to investigational Lily hair-loss prevention.
  • name: Dignitana
    why: DigniCap scalp cooling addresses chemotherapy hair loss.

keywords

  • oncology home infusion
  • chemotherapy at home
  • cancer care at home
  • oncology infusion capacity
  • chemotherapy hair loss prevention
  • home immunotherapy

voice

  • human and patient-centered
  • optimistic
  • clinically grounded

signals

  • text: Cancer center expanding infusion capacity or experiencing chair and staffing constraints.
  • text: Health plan launching a site-of-care or oncology cost reduction program.

pricing

model: unknown

motion

sales_led

channels

  • partnerships
  • industry events
  • press

confidence

medium

Founders

  • name: Aaron Hannon
    title: Founder
    role: Founder
    bio: Co-Founder and CEO of Luminate Medical. Software and electronic engineer with a passion for medical devices and a better citizen experience of medicine. Thiel Fellowship, Class of 2020.
  • name: Barbara Oliveira
    title: Founder
    role: Founder
    bio: Co-Founder and Clinical Lead of Luminate Medical, a start up medical device company based in Galway, Ireland working on empowering patients during their cancer & chemotherapy journey. Biomedical Engineer by background, with experience in leading first-in-human medical device clinical trials, and a passion for quality of life applications of medicine!

Back to YC companies